← Back to Search

Placebo

SCO-120 for Healthy Volunteer Study

Phase 1
Waitlist Available
Research Sponsored by Sun Pharma Advanced Research Company Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 42
Awards & highlights

Study Summary

This trial is testing a new drug to see if it is safe and how well it is tolerated by healthy male and female volunteers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 42
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 42 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Part A: Number of subjects with treatment-related adverse events as assessed by CTCAE version 5.0
Part C: Number of subjects with treatment-related adverse events as assessed by CTCAE version 5.0
Secondary outcome measures
Part B: Number of subjects with treatment-related adverse events as assessed by CTCAE version 5.0

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SCO-120Experimental Treatment1 Intervention
Group II: Matching PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SCO-120
2020
Completed Phase 1
~140

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Sun Pharma Advanced Research Company LimitedLead Sponsor
32 Previous Clinical Trials
4,447 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
2020. "Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04242953.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top